JORNALISMO E LITERATURA: ANÁLISE DO LIVRO-REPORTAGEM ESTAÇÃO CARANDIRU, DE DRÁUZIO VARELLA

Esta pesquisa caracteriza o tipo de narrador presente na obra Estação Carandiru, de Dráuzio Varella, discutindo as convergências e as divergências entre Jornalismo e Literatura. Inicialmente faremos um breve resgate histórico sobre o New Journalism e discorreremos sobre a prática jornalística na produção de livro-reportagem. O corpus de estudo é formado pelo livro Estação Carandiru, de Dráuzio Varella, publicado em 1999 pela editora Companhia das Letras. A metodologia baseou-se em uma revisão bibliográfica e pesquisa de caráter qualitativo, tendo como base teórica os estudos propostos por Felipe Pena (2006), Edivaldo Pereira Lima (2009), Rildo Cosson (2007), Marcelo Bulhões (2007) e Maria Ligia Chiappini Moraes Leite (2002). A partir da pesquisa realizada, conclui-se que o Jornalismo Literário ainda é pouco produzido pelos jornalistas contemporâneos, por estes ainda estarem influenciados pelo Jornalismo Norte americano, em que valorizam o lide, o imediatismo, pautado na veiculação de informação em tempo real

OBESIDADE INFANTIL E HIPERGLICEMIA: A IMPORTÂNCIA DA ORIENTAÇÃO PARA A PREVENÇÃO DO DIABETES MELLITUS TIPO II EM CRIANÇAS E ADOLESCENTES

Introdução: A obesidade infantil é definida pelo acúmulo de gordura corporal em associação ao consumo excessivo de calorias juntamente com o sedentarismo, é uma doença que cresce gradativamente em todo o mundo e tem capacidade de desenvolver hiperglicemia por resistência insuliníca, diminuindo dessa forma a sensibilidade do organismo à presença de insulina e, portanto, a mesma não consegue desempenhar adequadamente sua função, que é carrear a glicose presente no sangue para o interior das células. Como resultado, há um aumento no desenvolvimento de doenças cardiovasculares e metabólicas, como por exemplo, o diabetes mellitus tipo II, também conhecido por "diabetes mellitus insulinoindependente ", que é quando o corpo não consegue utilizar eficientemente a insulina que é produzida ou ocorre quando o pâncreas não sintetiza insulina suficiente que seria capaz de controlar o nível de glicose circulante. Assim sendo, foi apontado que a obesidade é uma condição considerada reversível, podendo ser diagnosticada com base no Índice de Massa Corporal (IMC), ressaltando que a prevenção durante a infância e adolescência é de extrema importância, pois contribuirá para uma melhor qualidade de vida no futuro. Objetivo: Relatar de forma sucinta o desenvolvimento da obesidade infantil e da hiperglicemia, a fim de relacionar essas complicações ao aparecimento do diabetes mellitus tipo II e correlacionar a orientação e a interação familiar e profissional com a prevenção. Metodologia: Trata-se de uma revisão literária onde a metodologia adotada foi à busca de artigos de revistas científicas, livros, dissertações, teses, monografias, sites como o do Ministério da Saúde, Sociedade Brasileira de Diabetes, ANVISA e de fontes de buscas como scielo, bireme, que foram publicados nos últimos 15 anos. A partir disso, 53 estudos foram identificados de acordo com o período descrito e no decorrer das leituras dos mesmos, foram excluídos aqueles que não contribuíram para o fornecimento de informações necessárias para o presente trabalho, restando apenas 27 estudos que conseguiram fornecer estritamente conhecimentos em relação ao tema do trabalho. Considerações finais: Observou-se que a orientação como forma de prevenção e a interação familiar e multidisciplinar desperta no público infantojuvenil o desejo de buscar hábitos saudáveis ??que proporcionem uma saúde equilibrada no futuro. Verificou-se que a associação de exercícios físicos com alimentação saudável não só ajuda a manter ou perder o peso, como também contribui para a prevenção de diversas doenças, incluindo diabetes mellitus tipo II, doenças cardiovasculares, depressão, fortalecimento dos ossos e músculos e auxilia no fornecimento, no caso dos alimentos, de uma variabilidade de nutrientes que irão atuar para promover uma melhor qualidade de vida

Extracts and Essential Oils from Medicinal Plants and Their Neuroprotective Effect

Current therapies for neurodegenerative diseases offer only limited benefits to their clinical symptoms and do not prevent the degeneration of neuronal cells. Neurological diseases affect millions of people around the world, and the economic impact of treatment is high, given that health care resources are scarce. Thus, many therapeutic strategies to delay or prevent neurodegeneration have been the subject of research for treatment. One strategy for this is the use of herbal and essential oils of different species of medicinal plants because they have several bioactive compounds and phytochemicals with neuroprotective capacity. In addition, they respond positively to neurological disorders, such as dementia, oxidative stress, anxiety, cerebral ischemia, and oxidative toxicity, suggesting their use as complementary treatment agents in the treatment of neurological disorders

CORRELAÇÃO ENTRE FIBROEDEMAGELÓIDE E DOSAGEM DE ESTRADIOL

Introdução: O fibroedemagelóide (FEG) é considerado antiestético, de caráter multifatorial causando um mau funcionamento do sistema circulatório e das transformações do tecido conjuntivo, podendo resultar em dor local e até mesmo diminuição das atividades funcionais. O estrógeno influência de forma significativa no surgimento do FEG, pois ele pode modificar o equilíbrio das proteoglicanas e glicosaminoglicanas na substância fundamental amorfa. Objetivo: Avaliar a relação entre a dosagem de estradiol e o grau de acometimento do fibroedemagelóide. Métodos: Trata-se de uma pesquisa observacional descritivo, a amostra foi composta por 40 indivíduos do sexo feminino, com faixa etária entre 17 e 45 anos de idade. A avaliação foi realizada através do PAFEG (validado) para análise do grau e forma clínica do FEG e também foi realizado exame da dosagem de estradiol na fase ovulatória de cada participante, ou seja, no 14º dia de um ciclo menstrual de 28 dias. Resultados: Os valores de normalidade do estradiol nessa fase variam entre 49 a 450 pg. Os resultados encontrados foram baseados nos valores da média da dose de estradiol de cada grupo: 250,37 para o grupo de FEG grau 1, 241,48 para o grupo de FEG grau 2 e 178,34 pg para o grupo de grau 3, portanto, os valores de estradiol estão dentro da faixa de normalidade, independente do grau do FEG. De acordo com estes dados foi possível avaliar que uma correlação negativa entre dosagem de estradiol com o grau do fibroedemagelóide (p= 0,032) e com a idade (p= 0,046) esta correlação foi positiva e significativa. Conclusão: A verificação da falta de uma relação entre o FEG e os níveis de estradiol pode ser justificada pelo caráter multifatorial da celulite, bem como a influência desse hormônio nas adaptações do tecido adiposo e conjuntivo e os sistemas circulatório e linfático

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Copyright © 2018 The Author(s). Published by Elsevier Ltd. Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8-98·1) in Iceland, followed by 96·6 (94·9-97·9) in Norway and 96·1 (94·5-97·3) in the Netherlands, to values as low as 18·6 (13·1-24·4) in the Central African Republic, 19·0 (14·3-23·7) in Somalia, and 23·4 (20·2-26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1-93·6) in Beijing to 48·0 (43·4-53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6-68·8) in Goa to 34·0 (30·3-38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view - and subsequent provision - of quality health care for all populations

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Background: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97\ub71 (95% UI 95\ub78-98\ub71) in Iceland, followed by 96\ub76 (94\ub79-97\ub79) in Norway and 96\ub71 (94\ub75-97\ub73) in the Netherlands, to values as low as 18\ub76 (13\ub71-24\ub74) in the Central African Republic, 19\ub70 (14\ub73-23\ub77) in Somalia, and 23\ub74 (20\ub72-26\ub78) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91\ub75 (89\ub71-93\ub76) in Beijing to 48\ub70 (43\ub74-53\ub72) in Tibet (a 43\ub75-point difference), while India saw a 30\ub78-point disparity, from 64\ub78 (59\ub76-68\ub78) in Goa to 34\ub70 (30\ub73-38\ub71) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4\ub78-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20\ub79-point to 17\ub70-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17\ub72-point to 20\ub74-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view-and subsequent provision-of quality health care for all populations

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.

BACKGROUND: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. METHODS: Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita

Parceria entre farmacêutico e agente comunitário de saúde no contexto do uso racional de medicamentos

Parceria entre farmacêutico e agente comunitário de saúde no contexto do uso racional de medicamentos. O objetivo desse estudo foi realizar avaliação farmacoterapêutica dos pacientes hipertensos e/ou diabéticos, acompanhados pelo agente comunitário de saúde (ACS) e farmacêutico em nível domiciliar no município de Fortaleza. Trata-se de um estudo observacional, descritivo, transversal e prospectivo, com abordagem quantitativa, realizado com um grupo de pacientes atendidos em domicílio e acompanhados pelos ACS de uma Unidade Básica de Saúde da SER III. Foram visitados 28 pacientes no período do estudo, observando-se a prevalência do sexo feminino e pacientes idosos. No levantamento do número de medicamentos prescritos por paciente foi obtida uma média de 4,5 ± 2,75 medicamentos onde as classes terapêuticas mais prevalentes foram os diuréticos, inibidor da enzima conversora de angiotensina, anti-inflamatórios não-esteroides, hipoglicemiantes orais e antagonista de angiotensina II. A baixa adesão ao tratamento reflete um importante problema relacionado a medicamento de inefetividade não quantitativa devido à indisponibilidade do medicamento para dispensação. O estudo ainda identificou muitos medicamentos usados sem prescrição. Conclui-se que a implantação da atenção farmacêutica domiciliar ou ambulatorial pode contribuir favoravelmente para a segurança e eficácia da farmacoterapia, proporcionando redução dos problemas relacionados aos medicamentos